Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Aoxing Pharmaceutical Co. Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 6.12M 6.65M 8.13M 10.83M 12.74M
Cost of Goods Sold (COGS) incl. D&A 2.51M 3.92M 3.83M 5.15M 7.54M
COGS excluding D&A 1.86M 2.77M 2.75M 4.03M 6.55M
Depreciation & Amortization Expense 645,004 1.15M 1.08M 1.11M 990,128
Depreciation 645,004 - 910,926 1.02M 951,726
Amortization of Intangibles - - 168,619 98,396 38,402
Gross Income 3.61M 2.73M 4.31M 5.68M 5.2M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 7.19M 7.32M 5.46M 12.23M 8.53M
Research & Development 1.54M 929,598 577,951 1.48M 569,699
Other SG&A 5.65M 6.39M 4.88M 10.75M 7.96M
Other Operating Expense 0 0 0 0 0
Unusual Expense (5.1M) (1.91M) 13.4M 7.67M 0
EBIT after Unusual Expense 5.1M 1.91M (13.4M) (7.67M) 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 0 - 0 0 0
Equity in Affiliates (Pretax) 0 0 (132,311) (114,744) (104,715)
Interest Expense 2.43M 1.74M 1.86M 2.99M 5.19M
Gross Interest Expense 2.43M 1.74M 1.86M 2.99M 5.19M
Interest Capitalized 0 0 0 0 0
Pretax Income (907,829) (4.42M) (15.88M) (17.29M) (8.63M)
Income Tax (63,058) 779,286 0 0 0
Income Tax - Current Domestic - 779,286 - 1.71M (2.42M)
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - (176,469) (91,156)
Income Tax - Deferred Foreign 0 0 - (1.53M) 2.51M
Income Tax Credits - 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (844,771) (5.2M) (15.88M) (17.29M) (8.63M)
Minority Interest Expense (12,612) (276,329) (57,434) (486,388) (418,697)
Net Income (832,159) (4.93M) (15.82M) (16.8M) (8.22M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (832,159) (4.93M) (15.82M) (16.8M) (8.22M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (832,159) (4.93M) (15.82M) (16.8M) (8.22M)
EPS (Basic) (0.02) (0.11) (0.32) (0.34) (0.16)
Basic Shares Outstanding 45.58M 46.58M 49.35M 49.75M 49.86M
EPS (Diluted) (0.02) (0.11) (0.32) (0.34) (0.16)
Diluted Shares Outstanding 45.58M 46.58M 49.35M 49.75M 49.86M
EBITDA (2.94M) (3.44M) (70,365) (5.43M) (2.34M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.